 Cryotherapy cutaneous Kaposi sarcoma KS immune deficiency syndrome AIDS phase II trial response toxicity liquid nitrogen cryotherapy cutaneous lesions Kaposi sarcoma KS AIDS subjects biopsy-proven KS phase II clinical trial Subjects cutaneous KS indicator lesions liquid nitrogen cyrotherapy Treatment week intervals adequate healing time average treatments lesion mean follow-up time weeks range weeks treatment freeze-thaw cycles thaw times cycle complete response treated KS lesions minimum weeks completion therapy Greater cosmetic improvement KS Histopathology treated lesions cosmetic improvement Response tolerance therapy cell count presence symptoms previous chemotherapy Subjects prior history opportunistic infection OI likely response prior history OI Subjects cryotherapy local pain acetaminophen Secondary infection study cryotherapy subjects cutaneous KS lesions Liquid nitrogen cryotherapy primary therapy role treatment cutaneous KS lesions incomplete cosmetic improvement systemic therapies